1-8 of 8
Hans Eich
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comprehensive Analysis of Treatment Related Morbidity and Progression -Free Survival in the GHSG Phase III HD21 Trial

Peter Borchmann, Alden Moccia, Richard Greil, Gundolf Schneider, Mark S. Hertzberg, Valdete Schaub, Andreas Huettmann, Felix Keil, Valdete Schaub, Mathias Hänel, Urban Novak, Julia Meissner, Andreas Zimmermann, Stephan Mathas, Josée M Zijlstra, Alexander Fosså, Andreas Viardot, Bernd Hertenstein, Sonja Martin, Pratyush Giri, Peter Kamper, Daniel L. Molin, Stefanie Kreissl, Justin Ferdinandus, Michael Fuchs, Andreas Rosenwald, Wolfram Klapper, Hans Eich, Christian Baues, Michael Hallek, Markus Dietlein, Carsten Kobe, Volker Diehl
Journal: Blood
Blood (2023) 142 (Supplement 1): 3057.
https://doi.org/10.1182/blood-2023-188720
Published: 2023
Journal Articles

Treatment Related Morbidity in Patients with Classical Hodgkin Lymphoma: Results of the Ongoing, Randomized Phase III HD21 Trial By the German Hodgkin Study Group

Peter Borchmann, Alden Moccia, Richard Greil, Mark Hertzberg, Valdete Schaub, Andreas Hüttmann, Felix Keil, Judith Dierlamm, Mathias Haenel, Urban Novak, Julia Meissner, Andreas Zimmermann, Stephan Mathas, Josée M. Zijlstra, Alexander Fosså, Andreas Viardot, Bernd Hertenstein, Sonja Martin, Pratyush Giri, Peter Kamper, Daniel Molin, Stefanie Kreissl, Michael Fuchs, Gundolf Schneider, Andreas Rosenwald, Wolfram Klapper, Hans Eich, Christian Baues, Michael Hallek, Markus Dietlein, Carsten Kobe, Volker Diehl, Andreas Engert
Journal: Blood
Blood (2022) 140 (Supplement 1): 771–773.
https://doi.org/10.1182/blood-2022-165917
Published: 2022
Journal Articles

PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 By the German Hodgkin Study Group

Michael Fuchs, Helen Goergen, Carsten Kobe, MD, Hans Eich, MD, Christian Baues, MD, Richard Greil, MD, Stephanie Sasse, MD, Josée M Zijlstra, MD, Andreas Lohri, MD, Andreas Rosenwald, Bastian von Tresckow, MD, Volker Diehl, MD, Georg Kuhnert, Markus Dietlein, MD, Peter Borchmann, MD, Andreas Engert, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 925.
https://doi.org/10.1182/blood-2018-99-114519
Published: 2018
Journal Articles

Long-Term Efficacy of Reduced-Intensity Conditioning Compared to Standard Myeloablative Conditioning before Allogeneic Hemopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia in First Complete Remission: 10-Year Follow-up of a Prospective, Open-Label Randomized Phase III Trial

Frederick Fasslrinner, MD, Johannes Schetelig, MD, Andreas Burchert, MD, Michael Kramer, M.Sc., Rudolf Trenschel, MD, Ute Hegenbart, Michael Stadler, MD PhD, Kerstin Schäfer-Eckart, MD, Michael Bätzel, Hans Eich, MD, Rita Engenhart-Cabillic, MD, Mechthild Krause, MD, Peter Dreger, MD, Andreas Neubauer, MD, Gerhard Ehninger, Dietrich W Beelen, MD PhD, Wolfgang E. Berdel, Timo Siepmann, MD, Matthias Stelljes, MD, Martin Bornhäuser, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4586.
https://doi.org/10.1182/blood.V130.Suppl_1.4586.4586
Published: 2017
Journal Articles

Early Interim PET in Patients with Advanced-Stage Hodgkin's Lymphoma Treated within the Phase 3 GHSG HD18 Study

Peter Borchmann, MD, Helen Goergen, Carsten Kobe, MD, Andreas Lohri, MD, Richard Greil, MD, Dennis A. Eichenauer, Josée M Zijlstra, MD PhD, Jana Markova, MD, Julia Meissner, MD, Michaela Feuring-Buske, PD Dr., Andreas Hüttmann, MD, Judith Dierlamm, MD, Martin Sökler, MD, Stefan W. Krause, MD, Hans Eich, MD, Christian Baues, MD, Stefanie Kreissl, MD, Michael Fuchs, MD, Markus Dietlein, MD, Andreas Engert, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 737.
https://doi.org/10.1182/blood.V130.Suppl_1.737.737
Published: 2017
Journal Articles

Treatment of Early Stage Nodal Follicular Lymphoma Using Involved-Field Radiotherapy and Rituximab: Preliminary Results of the Mir Trial (phase II study of the German Low Grade Lymphoma Study Group (GLSG))

Klaus Herfarth, MD, Marianne Engelhard, MD, Peter Borchmann, MD, Karin Hohloch, MD, Volker Budach, MD, Andreas Viardot, MD, Mathias Witzens-Harig, MD, Hans Eich, MD, Wolfgang Hiddemann, MD, PhD, Martin Dreyling
Journal: Blood
Blood (2012) 120 (21): 1634.
https://doi.org/10.1182/blood.V120.21.1634.1634
Published: 2012
Journal Articles

PVAG (Prednisone, Vinblastine, Doxorubicin and Gemcitabine) In Elderly Patients with Intermediate or Advanced Stage Hodgkin Lymphoma: Final Results of a Phase II Study of the German Hodgkin Study Group (GHSG).

Boris Böll, MD, Teresa Halbsguth, MD, Helen Görgen, Henning Bredenfeld, MD, Hans Eich, Michael Fuchs, Peter Borchmann, MD, Andreas Engert, MD
Journal: Blood
Blood (2010) 116 (21): 2827.
https://doi.org/10.1182/blood.V116.21.2827.2827
Published: 2010
Journal Articles

Assessment of Residual Bulky Tumor Using FDG-PET In Patients with Advanced-Stage Hodgkin Lymphoma After Completion of Chemotherapy: Final Report of the GHSG HD15 Trial

Andreas Engert, MD, Carsten Kobe, Jana Markova, Heinz Haverkamp, Peter Borchmann, Felicitas Hitz, Josee Zijlstra, Hans Eich, Rolf-Peter Mueller, Markus Dietlein, Volker Diehl
Journal: Blood
Blood (2010) 116 (21): 764.
https://doi.org/10.1182/blood.V116.21.764.764
Published: 2010